The drug induced liver injury: tactics of diagnosis and treatment
Journal Title: Сучасна гастроентерологія - Year 2018, Vol 0, Issue 1
Abstract
The article presents data of the drug induced liver injury, that plays an important role in the general structure of liver pathology. The basic directions of therapeutic correction of the drug induced liver injury been presented. The use of hepatoprotectors is one of the pathogenetically substantiated directions of treatment. Preparations of ursodeoxycholic acid proved to be the most effective and safe drugs with the wide clinical spectrum of application.
Authors and Affiliations
L. V. Zhuravlyova, I. O. Shekhovtsova
Keywords
Related Articles
- EP ID EP275746
- DOI -
- Views 136
- Downloads 0
State of the hepatobiliary system in boys with hypoandrogenism
Objective — to study the state of hepatobiliary system in boys/youths with delayed puberty. Materials and methods. The study involved 37 boys and youths with hypoandrogenism, aged 13 — 18 years, who were examined in the...
Ultrasound investigation of the brachial artery diameter as a non-invasive method for exposure of endothelial dysfunction in patients with ischemic heart disease and concomitant gastroesophageal reflux disease
Objective — to assess endothelial dysfunction in patients with ischemic heart disease (IHD) with concomitant gastroesophageal reflux disease (GERD) with the use of high-quality ultrasound imaging of the brachial artery....
Possibilities of correction of indicators of the humoral and cellular immunity by hepatoprotective ademetionine in the sportsmen of high professional qualification after the competitive period
Objective — to assess the efficacy of the hepatoprotector ademetionine for the correction of immune disorders in athletes of high professional qualification in the post-competitive period. Materials and methods. Examina...
Inflammatory bowel diseases; 14th Congress of the European Crohn’s and Colitis Organisation (ECCO)
-
Effects of L-ornithine-L-aspartate on the manifestation of minimal hepatic encephalopathy in the dynamics of cytostatic therapy
Objective — to investigate effects of the L-ornithine-L-aspartate (LOLA, Hepa-Merz®) on the clinical manifestations of minimal hepatic encephalopathy (HE) in patients with multiple myeloma (MM) in the dynamics of cytosta...